Molecular Imprints, Inc., an OTC-licensed startup spun out of UT Austin in 2001, recently announced that its semiconductor imprint lithography equipment business was purchased by Canon Inc. in a deal that will positively impact the industry.
Canon said that its nano-manufacturing division is set to become a new company that will keep the Molecular Imprints name. Based on technology discovered by Cockrell School of Engineering's S.V. Sreenivasan and C. Grant Willson—UT Austin's 2012 Inventors of the Year—Molecular Imprints' semiconductor imprint lithography equipment uses a cost-effective printing technique that reduces the size of circuits in computer chips and other devices.
OTC Tech News Brief
Research and startups
Æglea BioTherapeutics, a biotechnology startup based on technology licensed from the Office of Technology Commercialization at UT Austin, recently closed a $12 million Series A financing co-led by Lilly Ventures and Novartis Bioventures. Founded by UT Austin's Dr. George Georgiou and Dr. Everett Stone, Æglea was established to pursue the clinical development of engineered human enzymes.
As seen in BioNews Texas
Dr. Stephen Trent of UT Austin’s Institute of Cellular and
Molecular Biology has pioneered a process for harvesting a component of E. coli bacteria
that can be added to vaccines, which catalyzes stronger immune system reactions in patients.
OTC is working with Dr. Trent to market this technology to pharmaceutical companies,
» Read more at BioNews Texas